Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Stevanato Group announced the acquisition of a facility in Zhangjiagang for a new plant where the Company expects to begin renovations in the spring 2022, as part of the latest phase of its expansion in China.
read more
Stevanato Group and CEPI have signed an agreement for the supply of 100 million Type 1 Borosilicate glass vials for a vaccine against COVID-19 virus, should product(s) be proven safe and effective.
read more
Stevanato Group S.p.A. has secured €200 million in financing through agreements with BNL BNP Paribas, Cassa Depositi e Prestiti (CDP), and Banco BPM. These fundings are intended to support the Company’s ongoing capital expenditure projects in ...
read more
Wednesday, September 30, 2020
Stevanato Group has officially inaugurated its Technology Excellence Center in Boston, Massachusetts.
read more
Thursday, January 25, 2024
Stevanato Group S.p.A. , a global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, unveiled two new offerings for efficient small batch pharmaceutical manufacturing: the EZ-fill® ...
read more
Tuesday, January 26, 2021
Stevanato Group has launched an updated global after-sales service offering for pharmaceutical customers.
read more
Tuesday, October 21, 2025
Stevanato Group announced a significant expansion of its drug delivery systems manufacturing capacity at its Bad Oeynhausen facility in northern Germany, reinforcing the company’s global integration strategy across the pharmaceutical and ...
read more
Thursday, December 05, 2019
Italy-based Stevanato Group has broken ground on a new Technology Excellence Center in Boston.
read more
Stevanato Group S.p.A. announced the appointment of Ugo Gay as its new Chief Operations Officer (COO).
The addition of Ugo Gay underscores Stevanato Group’s unwavering commitment to driving operational efficiency, process standardization, and ...
read more
Thursday, November 18, 2021
Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the expansion of its corporate headquarters with the construction of a ...
read more
Stevanato Group S.p.A. announced a collaboration with Contract Development and Manufacturing Organization (CDMO), Recipharm. Under the agreement, Stevanato Group will lend its 70+ years of manufacturing experience to support the development and ...
read more
An exclusive agreement to license the Axis-D pen-injector technology and intellectual property (IP) in the Therapeutic Area of Diabetes Care.
read more
Sterling Pharma Solutions has been invited to join a consortium of leading industrial innovators from across the chemical industry supply chain to accelerate the use of continuous manufacturing in a range of industries, with digitalisation at its ...
read more
Sterling Pharma Solutions has signed an agreement with Moleculin Biotech to support the company’s expanded development efforts for its potential COVID-19 treatment, WP1122.
read more
Wednesday, April 24, 2019
Sterling Pharma Solutions, has received a Queen’s Award for International Trade for Outstanding Short Term Growth in overseas sales.
read more